Loading provider…
Loading provider…
Cardiovascular Disease Physician in Tacoma, WA
NPI: 1144204355Primary Practice Location
TACOMA GENERAL ALLENMORE HOSPITAL
1901 S Union Ave, Tacoma, WA
Primary Employer
Multicare Health System
multicare.org
HQ Phone
Get MD Vinay's Phone NumberMobile
Get MD Vinay's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardWA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 706 | 959 |
| 2 | 93306Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | 706 | 716 |
| 3 | 93010Routine electrocardiogram (EKG) using at least 12 leads with interpretation and report | 519 | 576 |
| 4 | 763763D radiographic procedure | 200 | 202 |
| 5 | 93015Exercise or drug-induced heart and blood vessel stress test with EKG monitoring, physician supervision, interpretation, and report | 126 | 126 |
Authors: Mark Hlatky, Rory Hachamovitch, Jeffrey Anderson, Frederick Masoudi, Daniel Mark, Michael Mcconnell, Jill Jacobs, Jeffrey Brinker, Daniel Edmundowicz, Geoffrey Rubin
Journal: J Am Coll Cardiol
Outcomes of anatomical versus functional testing for coronary artery disease.
Authors: Daniel Mark, James Udelson, Mitchell Krucoff, Lawton Cooper
Journal: N Engl J Med
Publication Date: 2015-03-14
Lead Sponsor: Celularity Incorporated
Collaborators: California Institute for Regenerative Medicine (CIRM), Access to Advanced Health Institute (AAHI), Lung Biotechnology PBC
Intervention / Treatment: BIOLOGICAL: CYNK-001
Lead Sponsor: Karyopharm Therapeutics Inc
Intervention / Treatment: OTHER: Placebo, DRUG: Selinexor
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: Baricitinib